Status:
COMPLETED
Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery
Lead Sponsor:
Population Health Research Institute
Collaborating Sponsors:
Abbott Diagnostics Division
Conditions:
Vascular Death
Myocardial Infarction
Eligibility:
All Genders
18+ years
Brief Summary
Worldwide over 2 million adults (\>30,000 Canadians) undergo heart surgery annually. Although heart surgery provides important survival benefits, it is associated with potential major complications su...
Eligibility Criteria
Inclusion
- Age ≥ 18 years.
- Patients who have undergone cardiac surgery. This includes coronary artery bypass grafting and all open heart procedures such as valvular repairs/replacement.
Exclusion
- Previously enrolled in the VISION Cardiac Surgery Study.
- Patients who have undergone an isolated pericardial window, pericardiectomy, permanent pacemaker or defibrillator implantation.
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2025
Estimated Enrollment :
15989 Patients enrolled
Trial Details
Trial ID
NCT01842568
Start Date
May 1 2013
End Date
July 1 2025
Last Update
July 31 2025
Active Locations (24)
Enter a location and click search to find clinical trials sorted by distance.
1
Ronald Reagan Medical Centre, UCLA
Los Angeles, California, United States, 90095
2
Royal Prince Alfred Hospital
Sydney, New South Wales, Australia
3
Hospital de Clínicas de Porto Alegre - HCPA
Porto Alegre, Rio Grande do Sul, Brazil, 90035-903
4
Instituto de Cardiologia do RS
Porto Alegre, Rio Grande do Sul, Brazil, 90620-001